These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

722 related items for PubMed ID: 21508849

  • 1. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C, Accordini S, Nosè M, Stroup S, Purgato M, Girlanda F, Esposito E, Veronese A, Tansella M, Cipriani A, CHAT (Clozapine Haloperidol Aripiprazole Trial) Study Group.
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [Abstract] [Full Text] [Related]

  • 2. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial.
    Cipriani A, Accordini S, Nosè M, Purgato M, Girlanda F, Tansella M, Barbui C.
    J Clin Psychopharmacol; 2013 Aug; 33(4):533-7. PubMed ID: 23775051
    [Abstract] [Full Text] [Related]

  • 3. Aripiprazole: new drug. Just another neuroleptic.
    Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
    [Abstract] [Full Text] [Related]

  • 4. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.
    Andrezina R, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, McQuade RD.
    Curr Med Res Opin; 2006 Nov; 22(11):2209-19. PubMed ID: 17076982
    [Abstract] [Full Text] [Related]

  • 5. Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia?
    Karunakaran K, Tungaraza TE, Harborne GC.
    J Psychopharmacol; 2007 Jun; 21(4):453-6. PubMed ID: 17050662
    [Abstract] [Full Text] [Related]

  • 6. Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia.
    Nosè M, Accordini S, Artioli P, Barale F, Barbui C, Beneduce R, Berardi D, Bertolazzi G, Biancosino B, Bisogno A, Bivi R, Bogetto F, Boso M, Bozzani A, Bucolo P, Casale M, Cascone L, Ciammella L, Cicolini A, Cipresso G, Cipriani A, Colombo P, Dal Santo B, De Francesco M, Di Lorenzo G, Di Munzio W, Ducci G, Erlicher A, Esposito E, Ferrannini L, Ferrato F, Ferro A, Fragomeno N, Parise VF, Frova M, Gardellin F, Garzotto N, Giambartolomei A, Giupponi G, Grassi L, Grazian N, Grecu L, Guerrini G, Laddomada F, Lazzarin E, Lintas C, Malchiodi F, Malvini L, Marchiaro L, Marsilio A, Mauri MC, Mautone A, Menchetti M, Migliorini G, Mollica M, Moretti D, Mulè S, Nicholau S, Nosè F, Occhionero G, Pacilli AM, Pecchioli S, Percudani M, Piantato E, Piazza C, Pontarollo F, Pycha R, Quartesan R, Rillosi L, Risso F, Rizzo R, Rocca P, Roma S, Rossattini M, Rossi G, Rossi G, Sala A, Santilli C, Saraò G, Sarnicola A, Sartore F, Scarone S, Sciarma T, Siracusano A, Strizzolo S, Tansella M, Targa G, Tasser A, Tomasi R, Travaglini R, Veronese A, Ziero S.
    Trials; 2009 May 15; 10():31. PubMed ID: 19445659
    [Abstract] [Full Text] [Related]

  • 7. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY, Lee CI, Chiu NY, Kahn DA.
    J Psychiatr Pract; 2009 May 15; 15(3):221-6. PubMed ID: 19461396
    [Abstract] [Full Text] [Related]

  • 8. Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine.
    Mossaheb N, Spindelegger C, Asenbaum S, Fischer P, Barnas C.
    World J Biol Psychiatry; 2010 Mar 15; 11(2 Pt 2):502-5. PubMed ID: 20218805
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
    Daniel DG, Currier GW, Zimbroff DL, Allen MH, Oren D, Manos G, McQuade R, Pikalov AA, Crandall DT.
    J Psychiatr Pract; 2007 May 15; 13(3):170-7. PubMed ID: 17522560
    [Abstract] [Full Text] [Related]

  • 10. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.
    Chang JS, Ahn YM, Park HJ, Lee KY, Kim SH, Kang UG, Kim YS.
    J Clin Psychiatry; 2008 May 15; 69(5):720-31. PubMed ID: 18370574
    [Abstract] [Full Text] [Related]

  • 11. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.
    Shim JC, Shin JG, Kelly DL, Jung DU, Seo YS, Liu KH, Shon JH, Conley RR.
    Am J Psychiatry; 2007 Sep 15; 164(9):1404-10. PubMed ID: 17728426
    [Abstract] [Full Text] [Related]

  • 12. Benefits of combining aripiprazole to clozapine: three case reports.
    Rocha FL, Hara C.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1167-9. PubMed ID: 16647796
    [Abstract] [Full Text] [Related]

  • 13. Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study.
    Mitsonis CI, Dimopoulos NP, Mitropoulos PA, Kararizou EG, Katsa AN, Tsakiris FE, Katsanou MN.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):373-7. PubMed ID: 17092620
    [Abstract] [Full Text] [Related]

  • 14. An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia.
    Henderson DC, Kunkel L, Nguyen DD, Borba CP, Daley TB, Louie PM, Freudenreich O, Cather C, Evins AE, Goff DC.
    Acta Psychiatr Scand; 2006 Feb 30; 113(2):142-7. PubMed ID: 16423166
    [Abstract] [Full Text] [Related]

  • 15. Combination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophrenia.
    Ziegenbein M, Sieberer M, Calliess IT, Kropp S.
    Aust N Z J Psychiatry; 2005 Sep 30; 39(9):840-1. PubMed ID: 16168043
    [No Abstract] [Full Text] [Related]

  • 16. Aripiprazole augmentation in clozapine-associated obsessive-compulsive symptoms.
    Villari V, Frieri T, Fagiolini A.
    J Clin Psychopharmacol; 2011 Jun 30; 31(3):375-6. PubMed ID: 21532362
    [No Abstract] [Full Text] [Related]

  • 17. Add-on of aripiprazole improves outcome in clozapine-resistant schizophrenia.
    De Risio A, Pancheri A, Simonetti G, Giannarelli D, Stefanutto L, Gentile B.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun 01; 35(4):1112-6. PubMed ID: 21447367
    [Abstract] [Full Text] [Related]

  • 18. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
    Glick ID, Mankoski R, Eudicone JM, Marcus RN, Tran QV, Assunção-Talbott S.
    J Affect Disord; 2009 May 01; 115(1-2):18-26. PubMed ID: 19230981
    [Abstract] [Full Text] [Related]

  • 19. Aripiprazole as an adjunct to clozapine therapy in adolescents with early-onset schizophrenia: a retrospective chart review.
    Bachmann CJ, Lehr D, Theisen FM, Preiss M.
    Pharmacopsychiatry; 2009 Jul 01; 42(4):153-7. PubMed ID: 19585394
    [Abstract] [Full Text] [Related]

  • 20. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
    Andrezina R, Josiassen RC, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, Iwamoto T.
    Psychopharmacology (Berl); 2006 Oct 01; 188(3):281-92. PubMed ID: 16953381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.